Xu J - Search Results

1

SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer.

Wei Z, Xu J, Li W, Ou L, Zhou Y, Wang Y, Shi B. Wei Z, et al. Among authors: xu j. Front Mol Biosci. 2022 May 20;9:902220. doi: 10.3389/fmolb.2022.902220. eCollection 2022. Front Mol Biosci. 2022. PMID: 35669562 Free PMC article.

2

TCEAL2 as a Tumor Suppressor in Renal Cell Carcinoma is Associated with the Good Prognosis of Patients.

Zhou Y, Zhang Y, Li W, Xu J, He X, Li X, Wang Y. Zhou Y, et al. Among authors: xu j. Cancer Manag Res. 2020 Oct 2;12:9589-9597. doi: 10.2147/CMAR.S271647. eCollection 2020. Cancer Manag Res. 2020. PMID: 33061644 Free PMC article.

3

FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer.

Zhou Y, Ou L, Xu J, Yuan H, Luo J, Shi B, Li X, Yang S, Wang Y. Zhou Y, et al. Among authors: xu j. Cell Death Dis. 2021 Jul 2;12(7):668. doi: 10.1038/s41419-021-03933-z. Cell Death Dis. 2021. PMID: 34215720 Free PMC article.

4

Role of hypermethylated-lncRNAs in the prognosis of bladder cancer patients.

Luo J, Xu J, Ou L, Zhou Y, Yun H, Yang Y, Wu X, Wang Y. Luo J, et al. Among authors: xu j. J Int Med Res. 2021 Oct;49(10):3000605211049946. doi: 10.1177/03000605211049946. J Int Med Res. 2021. PMID: 34617815 Free PMC article.

5

FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and Invasion.

Ou L, Wei Z, Xu J, Li W, Zhou Y, Wang Y, Shi B. Ou L, et al. Among authors: xu j. Ann Clin Lab Sci. 2022 Mar;52(2):260-268. Ann Clin Lab Sci. 2022. PMID: 35414505

6

ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.

Xu J, Wang Y, Jiang J, Yin C, Shi B. Xu J, et al. J Transl Med. 2023 Jan 30;21(1):56. doi: 10.1186/s12967-023-03913-1. J Transl Med. 2023. PMID: 36717944 Free PMC article.

7

Renal pseudoaneurysm after holmium laser lithotripsy with flexible ureteroscopy: an unusual case report and literature review.

Yin C, Chen F, Jiang J, Xu J, Shi B. Yin C, et al. Among authors: xu j. J Int Med Res. 2023 Mar;51(3):3000605231162784. doi: 10.1177/03000605231162784. J Int Med Res. 2023. PMID: 36974990 Free PMC article. Review.

8

Identification of ATP6V0A4 as a potential biomarker in renal cell carcinoma using integrated bioinformatics analysis.

Xu J, Jiang J, Yin C, Wang Y, Shi B. Xu J, et al. Oncol Lett. 2023 Jul 11;26(3):366. doi: 10.3892/ol.2023.13952. eCollection 2023 Sep. Oncol Lett. 2023. PMID: 37559594 Free PMC article.

9

ITM2A inhibits the progression of bladder cancer by downregulating the phosphorylation of STAT3.

Jiang J, Xu J, Ou L, Yin C, Wang Y, Shi B. Jiang J, et al. Among authors: xu j. Am J Cancer Res. 2024 May 15;14(5):2202-2215. doi: 10.62347/KHCC9690. eCollection 2024. Am J Cancer Res. 2024. PMID: 38859860 Free PMC article.

10

HOXA1 promotes proliferation and metastasis of bladder cancer by enhancing SMAD3 transcription.

Chen S, Shu G, Wang G, Ye J, Xu J, Huang C, Yang S. Chen S, et al. Among authors: xu j. Pathol Res Pract. 2022 Nov;239:154141. doi: 10.1016/j.prp.2022.154141. Epub 2022 Sep 28. Pathol Res Pract. 2022. PMID: 36228347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67,113 results

Search Page

Filters